Search Within

Population Sciences Research Program

  1. "Nursing"
  2. "Center for Hematologic Malignancies"
  3. "American Association for Cancer Research"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Center for Hematologic Malignancies (6)
  2. Department of Medicine (6)
  3. Hematologic Malignancies, Division of (6)
  4. Nursing (6)
  5. Biostatistics Service (5)
  6. Epidemiology and Biostatistics (5)

More Groups

People
  1. Katherine Panageas (3)
  2. Alan Houghton (2)
  3. Andriy Derkach (2)
  4. Heather Landau (2)
  5. Jonathan Lewis (2)
  6. Kylee Maclachlan (2)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2010 (1)
  4. 2007 (1)
  5. 2002 (1)
  6. 2000 (1)
Publications
  1. Clinical Cancer Research (4)
  2. Molecular Cancer Therapeutics (1)
  3. Proceedings of the American Association for Cancer Research Annual Meeting (1)
Publishers
  1. American Association for Cancer Research (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sustained minimal residual disease negativity in multiple myeloma is associated with stool butyrate and healthier plant-based diets
    Journal Article

    Shah, U. A.; Maclachlan, K. H.; Derkach, A.; Salcedo, M.; Barnett, K.; Caple, J.; Blaslov, J.; Tran, L.; Ciardiello, A.; Burge, M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Initial whole-genome sequencing of plasma cell neoplasms in first responders and recovery workers exposed to the World Trade Center attack of September 11, 2001
    Journal Article

    Maura, F.; Diamond, B.; Maclachlan, K. H.; Derkach, A.; Yellapantula, V. D.; Rustad, E. H.; Hultcrantz, M.; Shah, U. A.; Hong, J.; Landau, H. J.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Sequential cytarabine and α-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia
    Journal Article

    Rosenblat, T. L.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Divgi, C. R.; Panageas, K. S.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Sgouros, G.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • A phase '2-1-2' study of two different doses and schedules of pralatrexate, a high affinity substrate for the reduced folate carrier (RFC-1), in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies
    Meeting Abstract

    O'Connor, O. A.; Hamlin, P.; Portlock, C.; Moskowitz, C.; Noy, A.; Straus, D.; Dumetrescu, O.; Sarasohn, D.; Neylon, E.; Hamelers, R.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • T-cell responses against tyrosinase 368-376(370D) peptide in HLA*A0201+ melanoma patients: Randomized trial comparing incomplete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, and QS-21 as immunological adjuvants
    Journal Article

    Schaed, S. G.; Klimek, V. M.; Panageas, K. S.; Musselli, C. M.; Butterworth, L.; Hwu, W. J.; Livingston, P. O.; Williams, L.; Lewis, J. J.; Houghton, A. N.; more...
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • Immunization of melanoma patients with both tyrosinase (370D) and gp100 (210M) peptides: Comparison of adjuvants and peptide immunogenicity
    Meeting Abstract

    Schaed, S. G.; Houghton, A. N.; Klimek, V. M.; Butterworth, L.; Hwu, W. J.; Livingston, P. O.; Panageas, K.; Williams, L.; Dantis, L.; Lewis, J. J.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save